CA - Crescita Therapeutics GAAP EPS of -C$0.06 revenue of C$3.03M November, 08 2023 09:11 AM CA Inc. 2023-11-08 09:11:38 ET More on Crescita Therapeutics Crescita Therapeutics announces approval of normal course issuer bid Financial information for Crescita Therapeutics For further details see: Crescita Therapeutics GAAP EPS of -C$0.06, revenue of C$3.03M